Breast Cancer Trial, Recruiting NCT07650305 Sponsor: National Cancer Institute, Egypt Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07650305
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a female diagnosed with breast cancer
  • You are between 18 and 65 years old
  • Your body weight falls within a moderate range (not underweight or significantly overweight, specifically a BMI between 20 and 35) (confirm with trial site)
  • You have been assessed by a doctor as having mild to moderate health complexity related to anaesthesia risk, known as ASA class II or III (confirm with trial site)
  • You are scheduled for a planned breast cancer surgery that involves removal of the breast and nearby lymph nodes (called a modified radical mastectomy with axillary dissection)

Who may not be able to join:

  • You do not wish to participate in the trial
  • You are younger than 18 or older than 65 years of age
  • Your body weight falls outside the accepted range (BMI below 20 or above 35)
  • You have serious or significant other health conditions (confirm with trial site for what counts as a "major" condition)
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cancer Institute, Egypt
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 August 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Total post-operative morphine consumption.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov